Back to XENE
JPMORGAN CHASE & CO XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
52
Latest value
$15M
Q2 2026
Peak value
$136.9M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $7K |
| Q1 2025 | $20K |
| Q1 2025 | $31.1M |
| Q1 2025 | $13.5M |
| Q1 2025 | $11K |
| Q1 2025 | $752K |
| Q1 2025 | $163K |
| Q2 2025 | $9K |
| Q2 2025 | $19K |
| Q2 2025 | $25.6M |
| Q2 2025 | $1.7M |
| Q2 2025 | $12K |
| Q2 2025 | $11.8M |
| Q2 2025 | $145K |
| Q3 2025 | $11K |
| Q3 2025 | $482 |
| Q3 2025 | $33.5M |
| Q3 2025 | $24K |
| Q3 2025 | $10K |
| Q3 2025 | $2.1M |
| Q3 2025 | $20.2M |
| Q3 2025 | $206K |
| Q3 2025 | $11K |
| Q3 2025 | $482 |
| Q3 2025 | $33.5M |
| Q3 2025 | $24K |
| Q3 2025 | $10K |
| Q3 2025 | $2.1M |
| Q3 2025 | $20.2M |
| Q3 2025 | $206K |
| Q4 2025 | $12K |
| Q4 2025 | $241K |
| Q4 2025 | $39.6M |
| Q4 2025 | $27K |
| Q4 2025 | $2.5M |
| Q4 2025 | $24.6M |
| Q4 2025 | $11K |
| Q1 2026 | $15K |
| Q1 2026 | $3.3M |
| Q1 2026 | $36K |
| Q1 2026 | $73M |
| Q1 2026 | $13K |
| Q1 2026 | $349K |
| Q1 2026 | $30.2M |
| Q1 2026 | $1.6M |
| Q2 2026 | $14K |
| Q2 2026 | $4.9M |
| Q2 2026 | $43K |
| Q2 2026 | $136.9M |
| Q2 2026 | $14K |
| Q2 2026 | $435K |
| Q2 2026 | $15M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $15M | 249.7K | — | — |
| Q2 2026 | $435K | 7.2K | — | — |
| Q2 2026 | $14K | 240 | — | — |
| Q2 2026 | $136.9M | 2.28M | — | — |
| Q2 2026 | $43K | 707 | — | — |
| Q2 2026 | $4.9M | 81.8K | — | — |
| Q2 2026 | $14K | 238 | — | — |
| Q1 2026 | $1.6M | 29.4K | — | — |
| Q1 2026 | $30.2M | 543.3K | — | — |
| Q1 2026 | $349K | 6.3K | — | — |
| Q1 2026 | $13K | 240 | — | — |
| Q1 2026 | $73M | 1.31M | — | — |
| Q1 2026 | $36K | 651 | — | — |
| Q1 2026 | $3.3M | 58.6K | — | — |
| Q1 2026 | $15K | 274 | — | — |
| Q4 2025 | $11K | 240 | — | — |
| Q4 2025 | $24.6M | 549.1K | — | — |
| Q4 2025 | $2.5M | 56.0K | — | — |
| Q4 2025 | $27K | 606 | — | — |
| Q4 2025 | $39.6M | 882.5K | — | — |
| Q4 2025 | $241K | 5.4K | — | — |
| Q4 2025 | $12K | 274 | — | — |
| Q3 2025 | $206K | 5.1K | — | — |
| Q3 2025 | $20.2M | 504.3K | — | — |
| Q3 2025 | $2.1M | 53.0K | — | — |
| Q3 2025 | $10K | 240 | — | — |
| Q3 2025 | $24K | 606 | — | — |
| Q3 2025 | $33.5M | 835.5K | — | — |
| Q3 2025 | $482 | 12 | — | — |
| Q3 2025 | $11K | 273 | — | — |
| Q3 2025 | $206K | 5.1K | — | — |
| Q3 2025 | $20.2M | 504.3K | — | — |
| Q3 2025 | $2.1M | 53.0K | — | — |
| Q3 2025 | $10K | 240 | — | — |
| Q3 2025 | $24K | 606 | — | — |
| Q3 2025 | $33.5M | 835.5K | — | — |
| Q3 2025 | $482 | 12 | — | — |
| Q3 2025 | $11K | 273 | — | — |
| Q2 2025 | $145K | 4.6K | — | — |
| Q2 2025 | $11.8M | 377.3K | — | — |
| Q2 2025 | $12K | 387 | — | — |
| Q2 2025 | $1.7M | 55.7K | — | — |
| Q2 2025 | $25.6M | 817.7K | — | — |
| Q2 2025 | $19K | 606 | — | — |
| Q2 2025 | $9K | 273 | — | — |
| Q1 2025 | $163K | 4.9K | — | — |
| Q1 2025 | $752K | 22.4K | — | — |
| Q1 2025 | $11K | 333 | — | — |
| Q1 2025 | $13.5M | 402.6K | — | — |
| Q1 2025 | $31.1M | 926.5K | — | — |
| Q1 2025 | $20K | 606 | — | — |
| Q1 2025 | $7K | 209 | — | — |
Other funds holding XENE
$143.4M
$118.9M
$118.9M
$100M
$89.1M
$82.9M